相关实验视频
Updated: Jun 22, 2026

12:44
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
软组织 SARCOMA - SANTA CASA DE SÃO PAULO 从2006年到2019年的经验
Bruna Buscharino1, Anderson Rodrigues Dos Santos1, Dante Galvanese Amato Neto1
1Santa Casa de Misericórdia de São Paulo, Departamento de Ortopedia e Traumatologia, São Paulo, SP, Brazil.
Acta ortopedica brasileira
|July 20, 2023
概括
这项研究审查了软组织肉瘤 (STS) 治疗方法和结果. 接受非专业手术的患者有更多的局部复发,肺转移减少了生存率.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 整形外科 整形外科 整形外科
背景情况:
- 软组织瘤 (STS) 是一组多样化的恶性瘤.
- 了解它们的流行病学,治疗和生存对于患者的治疗结果至关重要.
研究的目的:
- 进行软组织肉瘤的流行病学审查.
- 分析STS患者的治疗,进化和生存模式.
主要方法:
- 对121名从2006年至2019年接受治疗的STS患者进行了回顾性研究.
- 分析患者数据,包括人口统计,组织学,瘤位置,治疗和结果.
- 评估局部复发,肺转移和生存率.
主要成果:
- 大腿是最常见的瘤位置.
- 由非专业化手术小组治疗的患者表现出更高的局部复发率.
- 肺转移的存在与显著较低的存活率有关.
结论:
- 软组织肉瘤发生率和组织学类型因患者年龄而异.
- 外科专业知识对STS的局部复发率产生影响.
- 肺转移是STS生存的关键预后因素.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

